These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 30972640)

  • 1. Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis.
    Ding X; Li Q; Li P; Zhang T; Cui B; Ji G; Lu X; Zhang F
    Drug Saf; 2019 Jul; 42(7):869-880. PubMed ID: 30972640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.
    Fang H; Fu L; Li X; Lu C; Su Y; Xiong K; Zhang L
    Microb Cell Fact; 2021 Jan; 20(1):18. PubMed ID: 33468164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
    Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ
    Lancet; 2017 Mar; 389(10075):1218-1228. PubMed ID: 28214091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis.
    Cui B; Li P; Xu L; Zhao Y; Wang H; Peng Z; Xu H; Xiang J; He Z; Zhang T; Nie Y; Wu K; Fan D; Ji G; Zhang F
    J Transl Med; 2015 Sep; 13():298. PubMed ID: 26363929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis.
    Dang X; Xu M; Liu D; Zhou D; Yang W
    PLoS One; 2020; 15(3):e0228846. PubMed ID: 32182248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS
    Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes.
    Li Q; Ding X; Liu K; Marcella C; Liu X; Zhang T; Liu Y; Li P; Xiang L; Cui B; Wang J; Bai J; Zhang F
    Clin Transl Gastroenterol; 2020 Aug; 11(8):e00224. PubMed ID: 32955197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study.
    Tian Y; Zhou Y; Huang S; Li J; Zhao K; Li X; Wen X; Li XA
    BMC Gastroenterol; 2019 Jul; 19(1):116. PubMed ID: 31272391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
    Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
    J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.
    El Hage Chehade N; Ghoneim S; Shah S; Chahine A; Mourad FH; Francis FF; Binion DG; Farraye FA; Hashash JG
    Inflamm Bowel Dis; 2023 May; 29(5):808-817. PubMed ID: 35766805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older patients benefit more from sequential courses of washed microbiota transplantation than younger population with ulcerative colitis.
    Liu Y; Ji X; Huang Y; Li Q; Ding X; Wang Y; Zhang S; Wen Q; Cui B; Lu X; Zhang F
    Scand J Gastroenterol; 2023; 58(8):890-899. PubMed ID: 36864569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory ulcerative colitis stabilized by interval washed microbiota transplantation: less is more.
    Wang Y; Cui B; Zhang F
    Curr Med Res Opin; 2022 Apr; 38(4):531-534. PubMed ID: 35040380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
    Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
    JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
    Rossen NG; Fuentes S; van der Spek MJ; Tijssen JG; Hartman JH; Duflou A; Löwenberg M; van den Brink GR; Mathus-Vliegen EM; de Vos WM; Zoetendal EG; D'Haens GR; Ponsioen CY
    Gastroenterology; 2015 Jul; 149(1):110-118.e4. PubMed ID: 25836986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of fecal microbiota transplantation by washed preparation in patients with moderate to severely active ulcerative colitis.
    Chen M; Liu XL; Zhang YJ; Nie YZ; Wu KC; Shi YQ
    J Dig Dis; 2020 Nov; 21(11):621-628. PubMed ID: 32909356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Siderophore-harboring gut bacteria and fecal siderophore genes for predicting the responsiveness of fecal microbiota transplantation for active ulcerative colitis.
    Yan J; Zhou G; Ren R; Zhang X; Zhang N; Wang Z; Peng L; Yang Y
    J Transl Med; 2024 Jun; 22(1):589. PubMed ID: 38915068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora.
    Wei Y; Gong J; Zhu W; Tian H; Ding C; Gu L; Li N; Li J
    BMC Microbiol; 2016 Nov; 16(1):255. PubMed ID: 27809778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis.
    Kump P; Wurm P; Gröchenig HP; Wenzl H; Petritsch W; Halwachs B; Wagner M; Stadlbauer V; Eherer A; Hoffmann KM; Deutschmann A; Reicht G; Reiter L; Slawitsch P; Gorkiewicz G; Högenauer C
    Aliment Pharmacol Ther; 2018 Jan; 47(1):67-77. PubMed ID: 29052237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fecal microbiota transplantation for the treatment of ulcerative colitis: a Meta-analysis].
    Mo R; Ren RR; Zhang XW; Yang YS
    Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):202-208. PubMed ID: 30803179
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancing patient adherence to fecal microbiota transplantation maintains the long-term clinical effects in ulcerative colitis.
    Li Q; Zhang T; Ding X; Xiang L; Cui B; Buch H; Zhang F
    Eur J Gastroenterol Hepatol; 2020 Aug; 32(8):955-962. PubMed ID: 32282545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.